The Comparison of Thick Split-thickness Skin Graft Versus Thin Split-thickness Skin Graft
1 other identifier
interventional
40
1 country
1
Brief Summary
In clinical settings, split-thickness skin graft (STSG) remain the gold standard for covering large skin defects. However, STSGs usually bring complications to the donor sites. The study objective was to compare the efficacy of thick split-thickness skin graft versus thin split-thickness skin graft in the reconstruction of the donor site.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2022
CompletedFirst Submitted
Initial submission to the registry
October 6, 2022
CompletedFirst Posted
Study publicly available on registry
October 7, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 10, 2022
CompletedOctober 13, 2022
October 1, 2022
7 months
October 6, 2022
October 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
healing time of the donor sites
The complete healing time of the donor sites was defined as the day when 100% epithelialization was achieved,
2 months post surgery
Secondary Outcomes (4)
life quality (36-item short form health survey scores)
Prior to surgery or at 6 months post-surgery
pains scores (Visual Analogue Scales)
on Day 1 and Day 7 postoperatively
pruritus scores
at 3 months and at 6 months post-surgery
scars scores ( Vancouver Scar Scales )
at 3 months and 6 months post-surgery
Study Arms (2)
the thick STSG group
EXPERIMENTALFor the patients in the thick STSG group, the surgeons harvested thick STSGs which were larger than recipient sites. The extra skin was punctured and stretched to cover the donor site (the novel technique).
the thin STSG group
ACTIVE COMPARATORFor the patients in the thin STSG group, the surgeons harvested thick STSGs of the size of recipient sites. Their donor sites were covered with thin STSGs which were harvested from other parts of the patients.
Interventions
For all the patients, thick STSGs (at a depth of 0.7 mm) were harvested from the upper lateral thighs to repair skin defects at functional sites or joint sites. For patients in the thick STSG group, the surgeons harvested a larger size of thick STSGs than the size of recipient sites. The size of the donor site was 150% - 200% of the size of the recipient site. Part of the thick STSG was grafted onto the recipient site. Subsequently, the leftover skin was punctured (in 1.5:1 mesh ratio) and stretched to obtain expansion. The donor site was covered by the leftover skin completely. In other words, the donor site was reconstructed by resurfacing the large sheet of thick STSG in situ. For patients in the thin STSG group, the surgeons harvested thick STSGs of the size of recipient sites. Their donor sites were covered with a large sheet of thin STSGs (at a depth of 0.4 mm) which were harvested from other parts of the patients.
Eligibility Criteria
You may qualify if:
- Patients had skin defects at functional sites or joint sites.
- Patients aged 20-80 years.
- The lateral thighs were chosen as the donor sites.
You may not qualify if:
- Patients who were unable to complete the follow-up.
- Pregnant or nursing mothers were not included.
- Patients had an alternative source of pain other than surgical sites.
- Patients with organ dysfunctions (heart failure, respiratory failure, liver dysfunction, renal impairment or intestinal failure), or cancers.
- Patients with autoimmune diseases (rheumatoid arthritis, ankylosing spondylitis, systemic lupus erythematosus, Sjogren's syndrome, connective tissues disease or systemic vasculitis) were not included.
- Patients who had medications (such as corticosteroids, immunosuppressive agents or chemotherapy) within six months were not included.
- Other reasons.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanjing First Hospital
Nanjing, Jiangsu, 210029, China
Related Publications (1)
Bian Y, Sun C, Zhang X, Li Y, Li W, Lv X, Li J, Jiang L, Li J, Feng J, Li XY. Wound-healing improvement by resurfacing split-thickness skin donor sites with thin split-thickness grafting. Burns. 2016 Feb;42(1):123-130. doi: 10.1016/j.burns.2015.07.008. Epub 2015 Nov 23.
PMID: 26615713BACKGROUND
Related Links
Study Officials
- STUDY DIRECTOR
Rong Wu, phD
The First Affiliated Hospital with Nanjing Medical University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- attending doctor of Department of Burn and Plastic Surgery,Nanjing First Hospital
Study Record Dates
First Submitted
October 6, 2022
First Posted
October 7, 2022
Study Start
May 1, 2022
Primary Completion
December 1, 2022
Study Completion
December 10, 2022
Last Updated
October 13, 2022
Record last verified: 2022-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
- Time Frame
- December,31,2023
- Access Criteria
- no limits
The study protocol, Iinformed Consent Form will be shared on the website:http://www.stats.gov.cn/tjsj/